Journal Basic Info

  • Impact Factor: 2.709**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Ovarian Cancer
  •  Radiation Therapy
  •  Pancreatic Cancer
  •  Melanoma/Skin Cancer
  •  Gastrointestinal Cancer
  •  Lymphoma
  •  Neoadjuvant Therapy
  •  Cervical Cancer

Abstract

Citation: Clin Oncol. 2017;2(1):1210.DOI: 10.25107/2474-1663.1210

Mir-17-92 Cluster Dysregulation in Lymphoid Malignancies: Its Role in Limphomagenesis

Alejandro Roisman and Irma Slavutsky

Laboratory of Genetics of Lymphoid Neoplasms, Institute of Experimental Medicine, Argentina

*Correspondance to: Irma Slavutsky 

 PDF  Full Text Editorial | Open Access

Abstract:

MicroRNAs (miRNAs) are short, endogenous singled-stranded noncoding RNAs whose dysregulation has been implicated in important biologic processes, including cancer development. The principal mechanism of action of these master regulators is to control gene expression by suppressing mRNA translation and reducing mRNA stability. In particular, the miR-17-92 cluster is one of the most frequently miRNA expressed in different subtypes of non-Hodgkin lymphomas. Its widespread dysregulation in these pathologies suggests this cluster as a new biomarker that may supplement lymphoma diagnosis and prognosis, and also as an attractive target to design novel strategies for cancer therapy.

Keywords:

Cite the Article:

Roisman A, Slavutsky I. Mir- 17-92 Cluster Dysregulation in Lymphoid Malignancies: Its Role in Limphomagenesis. Clin Oncol. 2017; 2: 1210.

Search Our Journal

Journal Indexed In

Articles in PubMed

LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma
 PubMed  PMC  PDF  Full Text
Metastatic Retroperitoneal Paraganglioma: Case Report and Review of the Literature
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Clinical and Morphological Heterogeneity of the Xp11.2 Translocation Renal Cell Carcinoma
 Abstract  PDF  Full Text
Charlson Comorbidity Index as a Predictor of Cancer Mortality Beyond 10 Years after Radical Prostatectomy
 Abstract  PDF  Full Text
View More...